Skip to main content
. 2021 Jul 15;11(7):664. doi: 10.3390/jpm11070664

Figure 1.

Figure 1

Biomarker assays and their use in PC management. AR-V7, androgen receptor splice variant 7; CTLA-4, cytotoxic T lymphocyte-associated protein-4; DRE, Digital rectal examination; mpMRI, multi-parametric magnetic resonance imaging; PC, Prostate cancer; PD-1, programmed death-1; PORTOS, Post-Operative Radiation Therapy Outcomes Score; PSA, Prostate specific antigen; PTEN, phosphatase and tensin homolog; TMB, Tumour mutational burden.